FDA

Skippy Recalls Over 161,000 Pounds of Peanut Butter

Skippy Foods issued a voluntary recall of its peanut butter jars on Wednesday. 

Texas AG Investigating Whether Pharma Companies Deceptively Advertised Puberty Blocking Drugs

The attorney general of Texas is demanding documents from the manufacturers of puberty-blocking drugs as part of an investigation probing whether they have engaged in practices that violate state law.

FDA OKs Another Pfizer/Moderna COVID Booster for 50 & Up

U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.

People’s Convoy Shifts Gears to Protest Proposed California Vaccine Laws

Truckers protesting the Biden administration’s reluctance to give up its COVID-19 pandemic-induced emergency powers are now headed to California to fight against proposed vaccine-related legislation.

In Lab Study, Pfizer Vaccine Showed Potential to Alter DNA in Human Liver Cells, but Scientists Caution More Research Needed

Swedish researchers showed the mRNA from the Pfizer COVID-19 vaccine can be reverse-transcribed into DNA in human liver cells in vitro, but more research is needed to determine if this transcribed vaccine-derived DNA can integrate into human genomic DNA.

44 Studies on Vaccine Efficacy That Raise Doubts on Vaccine Mandates

As some people have now been vaccinated for more than half a year, evidence is pouring in about Covid vaccine efficacy.

Malone, McCullough: Get Politics Out of Healthcare, Let Doctors Practice Medicine

Letting politicians dictate patient care, which prevents physicians from practicing medicine and saving patients’ lives, is a core problem, say Drs. Robert Malone and Peter McCullough.

$45 Million Paid to Victims of Covid Vax Injury in Thailand

Thailand pays out roughly $45 million to victims of COVID-19 vaccines so far.

Pfizer Pushes for 4th Shot, Says 3 Doses ‘Not That Good’ Against Infections

Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.

Latest news

- Advertisement -spot_img